| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription factor binding | APBB3 JARID2 PRAMEF17 RARA RARB RARG FHL2 STAT5A STAT5B KAT6A | 2.70e-06 | 753 | 42 | 10 | GO:0008134 |
| GeneOntologyMolecularFunction | extracellular matrix protein binding | 6.44e-05 | 6 | 42 | 2 | GO:1990430 | |
| GeneOntologyMolecularFunction | zinc ion binding | 7.95e-05 | 891 | 42 | 9 | GO:0008270 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.92e-04 | 582 | 42 | 7 | GO:0140297 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 2.10e-04 | 55 | 42 | 3 | GO:0042974 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 2.72e-04 | 60 | 42 | 3 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 2.86e-04 | 61 | 42 | 3 | GO:0098531 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 6.31e-04 | 187 | 42 | 4 | GO:0016922 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 6.83e-04 | 1189 | 42 | 9 | GO:0046914 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 1.06e-03 | 23 | 42 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 1.29e-03 | 102 | 42 | 3 | GO:0005249 | |
| GeneOntologyMolecularFunction | delayed rectifier potassium channel activity | 1.58e-03 | 28 | 42 | 2 | GO:0005251 | |
| GeneOntologyMolecularFunction | potassium channel activity | 2.46e-03 | 128 | 42 | 3 | GO:0005267 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell differentiation | 7.44e-06 | 19 | 42 | 3 | GO:0055012 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 1.07e-05 | 144 | 42 | 5 | GO:0045582 | |
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 1.21e-05 | 3 | 42 | 2 | GO:0046544 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | ACTL6A PLCG1 PRAMEF17 RARA CACUL1 RARG CD248 FNTB IL23R STAT5A STAT5B | 1.84e-05 | 1190 | 42 | 11 | GO:0008284 |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 1.89e-05 | 162 | 42 | 5 | GO:0045621 | |
| GeneOntologyBiologicalProcess | growth plate cartilage development | 2.76e-05 | 29 | 42 | 3 | GO:0003417 | |
| GeneOntologyBiologicalProcess | positive regulation of activated T cell proliferation | 3.74e-05 | 32 | 42 | 3 | GO:0042104 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell activation | 4.91e-05 | 35 | 42 | 3 | GO:0032816 | |
| GeneOntologyBiologicalProcess | negative regulation of cartilage development | 5.35e-05 | 36 | 42 | 3 | GO:0061037 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 6.30e-05 | 38 | 42 | 3 | GO:0048384 | |
| GeneOntologyBiologicalProcess | endochondral bone growth | 6.82e-05 | 39 | 42 | 3 | GO:0003416 | |
| GeneOntologyBiologicalProcess | glandular epithelial cell development | 9.15e-05 | 43 | 42 | 3 | GO:0002068 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 9.24e-05 | 226 | 42 | 5 | GO:0045580 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 9.88e-05 | 540 | 42 | 7 | GO:1903706 | |
| GeneOntologyBiologicalProcess | bone growth | 1.05e-04 | 45 | 42 | 3 | GO:0098868 | |
| GeneOntologyBiologicalProcess | trachea cartilage development | 1.12e-04 | 8 | 42 | 2 | GO:0060534 | |
| GeneOntologyBiologicalProcess | cartilage development involved in endochondral bone morphogenesis | 1.20e-04 | 47 | 42 | 3 | GO:0060351 | |
| GeneOntologyBiologicalProcess | myeloid cell differentiation | 1.21e-04 | 558 | 42 | 7 | GO:0030099 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 1.27e-04 | 242 | 42 | 5 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 1.27e-04 | 242 | 42 | 5 | GO:1903708 | |
| GeneOntologyBiologicalProcess | immune system development | 1.43e-04 | 248 | 42 | 5 | GO:0002520 | |
| GeneOntologyBiologicalProcess | taurine metabolic process | 1.44e-04 | 9 | 42 | 2 | GO:0019530 | |
| GeneOntologyBiologicalProcess | alkanesulfonate metabolic process | 1.44e-04 | 9 | 42 | 2 | GO:0019694 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | 1.45e-04 | 249 | 42 | 5 | GO:0035264 | |
| GeneOntologyBiologicalProcess | hematopoietic or lymphoid organ development | 1.53e-04 | 133 | 42 | 4 | GO:0048534 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway via JAK-STAT | 1.80e-04 | 10 | 42 | 2 | GO:0060397 | |
| GeneOntologyBiologicalProcess | development of secondary female sexual characteristics | 1.80e-04 | 10 | 42 | 2 | GO:0046543 | |
| GeneOntologyBiologicalProcess | regulation of activated T cell proliferation | 1.81e-04 | 54 | 42 | 3 | GO:0046006 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 1.98e-04 | 266 | 42 | 5 | GO:0045619 | |
| GeneOntologyBiologicalProcess | negative regulation of erythrocyte differentiation | 2.20e-04 | 11 | 42 | 2 | GO:0045647 | |
| GeneOntologyBiologicalProcess | response to interleukin-2 | 2.20e-04 | 11 | 42 | 2 | GO:0070669 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell activation | 2.60e-04 | 61 | 42 | 3 | GO:0032814 | |
| GeneOntologyBiologicalProcess | positive regulation of gamma-delta T cell differentiation | 2.64e-04 | 12 | 42 | 2 | GO:0045588 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell proliferation | 2.64e-04 | 12 | 42 | 2 | GO:0032819 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell differentiation | 2.64e-04 | 12 | 42 | 2 | GO:0032825 | |
| GeneOntologyBiologicalProcess | response to interleukin-15 | 2.64e-04 | 12 | 42 | 2 | GO:0070672 | |
| GeneOntologyBiologicalProcess | prostate gland development | 2.73e-04 | 62 | 42 | 3 | GO:0030850 | |
| GeneOntologyBiologicalProcess | regulation of myeloid cell differentiation | 2.86e-04 | 288 | 42 | 5 | GO:0045637 | |
| GeneOntologyBiologicalProcess | face development | 2.86e-04 | 63 | 42 | 3 | GO:0060324 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 2.95e-04 | 290 | 42 | 5 | GO:0050870 | |
| GeneOntologyBiologicalProcess | regulation of cell development | 2.95e-04 | 1095 | 42 | 9 | GO:0060284 | |
| GeneOntologyBiologicalProcess | development of secondary sexual characteristics | 3.11e-04 | 13 | 42 | 2 | GO:0045136 | |
| GeneOntologyBiologicalProcess | mucosa-associated lymphoid tissue development | 3.11e-04 | 13 | 42 | 2 | GO:0048537 | |
| GeneOntologyBiologicalProcess | Peyer's patch development | 3.11e-04 | 13 | 42 | 2 | GO:0048541 | |
| GeneOntologyBiologicalProcess | activated T cell proliferation | 3.14e-04 | 65 | 42 | 3 | GO:0050798 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | 3.32e-04 | 875 | 42 | 8 | GO:0045596 | |
| GeneOntologyBiologicalProcess | regulation of myelination | 3.43e-04 | 67 | 42 | 3 | GO:0031641 | |
| GeneOntologyBiologicalProcess | positive regulation of gamma-delta T cell activation | 3.63e-04 | 14 | 42 | 2 | GO:0046645 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell proliferation | 3.63e-04 | 14 | 42 | 2 | GO:0032817 | |
| GeneOntologyBiologicalProcess | columnar/cuboidal epithelial cell development | 3.75e-04 | 69 | 42 | 3 | GO:0002066 | |
| GeneOntologyBiologicalProcess | regulation of gamma-delta T cell differentiation | 4.18e-04 | 15 | 42 | 2 | GO:0045586 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 4.19e-04 | 906 | 42 | 8 | GO:0043009 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 4.43e-04 | 317 | 42 | 5 | GO:1903039 | |
| GeneOntologyBiologicalProcess | luteinization | 4.77e-04 | 16 | 42 | 2 | GO:0001553 | |
| GeneOntologyBiologicalProcess | embryo development | SEC24D ACTL6A PLCG1 PRAMEF17 RARA RARB RARG USPL1 LRP1B KAT6A | 4.90e-04 | 1437 | 42 | 10 | GO:0009790 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 4.96e-04 | 929 | 42 | 8 | GO:0009792 | |
| GeneOntologyBiologicalProcess | blastocyst formation | 5.37e-04 | 78 | 42 | 3 | GO:0001825 | |
| GeneOntologyBiologicalProcess | regulation of gamma-delta T cell activation | 5.40e-04 | 17 | 42 | 2 | GO:0046643 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 5.57e-04 | 79 | 42 | 3 | GO:0060350 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated cytotoxicity | 5.57e-04 | 79 | 42 | 3 | GO:0001912 | |
| GeneOntologyBiologicalProcess | urogenital system development | 5.57e-04 | 79 | 42 | 3 | GO:0001655 | |
| GeneOntologyBiologicalProcess | regulation of cartilage development | 6.00e-04 | 81 | 42 | 3 | GO:0061035 | |
| GeneOntologyBiologicalProcess | natural killer cell proliferation | 6.07e-04 | 18 | 42 | 2 | GO:0001787 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | 6.51e-04 | 1220 | 42 | 9 | GO:0051093 | |
| GeneOntologyBiologicalProcess | gamma-delta T cell differentiation | 7.51e-04 | 20 | 42 | 2 | GO:0042492 | |
| GeneOntologyBiologicalProcess | positive regulation of cell killing | 7.64e-04 | 88 | 42 | 3 | GO:0031343 | |
| GeneOntologyBiologicalProcess | positive regulation of B cell differentiation | 8.29e-04 | 21 | 42 | 2 | GO:0045579 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 8.29e-04 | 21 | 42 | 2 | GO:0032823 | |
| GeneOntologyBiologicalProcess | glandular epithelial cell differentiation | 8.42e-04 | 91 | 42 | 3 | GO:0002067 | |
| GeneOntologyBiologicalProcess | trachea development | 9.11e-04 | 22 | 42 | 2 | GO:0060438 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 1.03e-03 | 382 | 42 | 5 | GO:0030217 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 1.06e-03 | 385 | 42 | 5 | GO:0051251 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 1.11e-03 | 389 | 42 | 5 | GO:0022409 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 1.23e-03 | 596 | 42 | 6 | GO:0001701 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway | 1.28e-03 | 26 | 42 | 2 | GO:0060396 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | 1.36e-03 | 407 | 42 | 5 | GO:0045787 | |
| GeneOntologyBiologicalProcess | cellular response to growth hormone stimulus | 1.38e-03 | 27 | 42 | 2 | GO:0071378 | |
| GeneOntologyBiologicalProcess | negative regulation of chondrocyte differentiation | 1.38e-03 | 27 | 42 | 2 | GO:0032331 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid cell apoptotic process | 1.38e-03 | 27 | 42 | 2 | GO:0033033 | |
| GeneOntologyBiologicalProcess | cartilage development | 1.48e-03 | 243 | 42 | 4 | GO:0051216 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | 1.61e-03 | 423 | 42 | 5 | GO:0002696 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 1.72e-03 | 429 | 42 | 5 | GO:1902105 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | 1.77e-03 | 640 | 42 | 6 | GO:1903131 | |
| GeneOntologyBiologicalProcess | organ growth | 1.79e-03 | 256 | 42 | 4 | GO:0035265 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper cell differentiation | 1.81e-03 | 31 | 42 | 2 | GO:0045624 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 1.93e-03 | 32 | 42 | 2 | GO:2000353 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell proliferation | 1.93e-03 | 32 | 42 | 2 | GO:2000647 | |
| GeneOntologyBiologicalProcess | bone morphogenesis | 2.05e-03 | 124 | 42 | 3 | GO:0060349 | |
| GeneOntologyBiologicalProcess | natural killer cell activation | 2.05e-03 | 124 | 42 | 3 | GO:0030101 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 2.05e-03 | 124 | 42 | 3 | GO:0001910 | |
| GeneOntologyBiologicalProcess | gamma-delta T cell activation | 2.05e-03 | 33 | 42 | 2 | GO:0046629 | |
| GeneOntologyBiologicalProcess | prostate gland epithelium morphogenesis | 2.05e-03 | 33 | 42 | 2 | GO:0060740 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | 2.05e-03 | 447 | 42 | 5 | GO:1903037 | |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 2.09e-03 | 449 | 42 | 5 | GO:0050867 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell proliferation | 2.10e-03 | 125 | 42 | 3 | GO:0042102 | |
| GeneOntologyBiologicalProcess | circulatory system development | 2.11e-03 | 1442 | 42 | 9 | GO:0072359 | |
| GeneOntologyBiologicalProcess | prostate gland morphogenesis | 2.18e-03 | 34 | 42 | 2 | GO:0060512 | |
| GeneOntologyBiologicalProcess | regulation of T cell activation | 2.28e-03 | 458 | 42 | 5 | GO:0050863 | |
| MousePheno | fusion of atlas and odontoid process | 1.29e-06 | 10 | 32 | 3 | MP:0010701 | |
| MousePheno | absent metoptic pillar | 5.08e-06 | 2 | 32 | 2 | MP:0010705 | |
| MousePheno | abnormal cervical atlas morphology | 5.24e-06 | 51 | 32 | 4 | MP:0004607 | |
| MousePheno | abnormal odontoid process morphology | 8.69e-06 | 18 | 32 | 3 | MP:0004659 | |
| MousePheno | split cervical atlas | 3.04e-05 | 4 | 32 | 2 | MP:0010702 | |
| MousePheno | split cervical axis | 3.04e-05 | 4 | 32 | 2 | MP:0010703 | |
| MousePheno | abnormal optic canal morphology | 5.06e-05 | 5 | 32 | 2 | MP:0010704 | |
| MousePheno | abnormal cervical axis morphology | 6.21e-05 | 34 | 32 | 3 | MP:0004608 | |
| MousePheno | cervical vertebral transformation | 1.09e-04 | 41 | 32 | 3 | MP:0004615 | |
| MousePheno | vertebral transformation | 1.10e-04 | 110 | 32 | 4 | MP:0003036 | |
| MousePheno | cervical vertebral fusion | 1.18e-04 | 42 | 32 | 3 | MP:0004620 | |
| MousePheno | abnormal orbitosphenoid bone morphology | 1.41e-04 | 8 | 32 | 2 | MP:0004457 | |
| MousePheno | abnormal cervical vertebrae morphology | 1.54e-04 | 120 | 32 | 4 | MP:0003048 | |
| MousePheno | narrow eye opening | 1.99e-04 | 50 | 32 | 3 | MP:0005287 | |
| MousePheno | thoracic vertebral transformation | 2.11e-04 | 51 | 32 | 3 | MP:0004618 | |
| MousePheno | abnormal eyelid aperture | 3.25e-04 | 59 | 32 | 3 | MP:0003671 | |
| MousePheno | fusion of vertebral arches | 3.58e-04 | 61 | 32 | 3 | MP:0004613 | |
| MousePheno | fusion of atlas and occipital bones | 3.90e-04 | 13 | 32 | 2 | MP:0010728 | |
| MousePheno | abnormal cricoid cartilage morphology | 5.23e-04 | 15 | 32 | 2 | MP:0002258 | |
| MousePheno | abnormal orbit morphology | 7.59e-04 | 18 | 32 | 2 | MP:0010030 | |
| MousePheno | abnormal trachea morphology | 8.24e-04 | 81 | 32 | 3 | MP:0002282 | |
| Domain | Retinoic_acid_rcpt | 4.54e-08 | 4 | 43 | 3 | IPR003078 | |
| Domain | K_chnl_volt-dep_Kv2 | 5.18e-06 | 2 | 43 | 2 | IPR003973 | |
| Domain | Kv2channel | 5.18e-06 | 2 | 43 | 2 | PF03521 | |
| Domain | STAT_TF_prot_interaction | 1.08e-04 | 7 | 43 | 2 | IPR013799 | |
| Domain | STAT_TF_DNA-bd_sub | 1.08e-04 | 7 | 43 | 2 | IPR012345 | |
| Domain | STAT | 1.08e-04 | 7 | 43 | 2 | IPR001217 | |
| Domain | STAT_TF_coiled-coil | 1.08e-04 | 7 | 43 | 2 | IPR015988 | |
| Domain | - | 1.08e-04 | 7 | 43 | 2 | 2.60.40.630 | |
| Domain | STAT_int | 1.08e-04 | 7 | 43 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 1.08e-04 | 7 | 43 | 2 | IPR013801 | |
| Domain | STAT_bind | 1.08e-04 | 7 | 43 | 2 | PF02864 | |
| Domain | STAT_int | 1.08e-04 | 7 | 43 | 2 | PF02865 | |
| Domain | - | 1.08e-04 | 7 | 43 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 1.08e-04 | 7 | 43 | 2 | PF01017 | |
| Domain | - | 1.08e-04 | 7 | 43 | 2 | 1.20.1050.20 | |
| Domain | Ion_trans_dom | 1.35e-04 | 114 | 43 | 4 | IPR005821 | |
| Domain | Ion_trans | 1.35e-04 | 114 | 43 | 4 | PF00520 | |
| Domain | STAT_TF_alpha | 1.44e-04 | 8 | 43 | 2 | IPR013800 | |
| Domain | zf-C4 | 1.61e-04 | 46 | 43 | 3 | PF00105 | |
| Domain | Znf_hrmn_rcpt | 1.61e-04 | 46 | 43 | 3 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 1.61e-04 | 46 | 43 | 3 | IPR001723 | |
| Domain | NUCLEAR_REC_DBD_2 | 1.61e-04 | 46 | 43 | 3 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 1.61e-04 | 46 | 43 | 3 | PS00031 | |
| Domain | ZnF_C4 | 1.61e-04 | 46 | 43 | 3 | SM00399 | |
| Domain | - | 1.72e-04 | 47 | 43 | 3 | 1.10.565.10 | |
| Domain | HOLI | 1.83e-04 | 48 | 43 | 3 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 1.83e-04 | 48 | 43 | 3 | IPR000536 | |
| Domain | Hormone_recep | 1.83e-04 | 48 | 43 | 3 | PF00104 | |
| Domain | - | 3.05e-04 | 57 | 43 | 3 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 3.21e-04 | 58 | 43 | 3 | IPR013088 | |
| Domain | SH2 | 1.62e-03 | 101 | 43 | 3 | PF00017 | |
| Domain | K_chnl_volt-dep_Kv | 1.75e-03 | 27 | 43 | 2 | IPR003968 | |
| Domain | SH2 | 2.07e-03 | 110 | 43 | 3 | SM00252 | |
| Domain | SH2 | 2.12e-03 | 111 | 43 | 3 | PS50001 | |
| Domain | SH2 | 2.18e-03 | 112 | 43 | 3 | IPR000980 | |
| Domain | - | 2.18e-03 | 112 | 43 | 3 | 3.30.505.10 | |
| Domain | VG_K_chnl | 2.61e-03 | 33 | 43 | 2 | IPR028325 | |
| Domain | EGF-like_CS | 3.00e-03 | 261 | 43 | 4 | IPR013032 | |
| Domain | EGF_2 | 3.17e-03 | 265 | 43 | 4 | PS01186 | |
| Domain | Growth_fac_rcpt_ | 5.52e-03 | 156 | 43 | 3 | IPR009030 | |
| Domain | p53-like_TF_DNA-bd | 6.62e-03 | 53 | 43 | 2 | IPR008967 | |
| Domain | BTB_2 | 6.62e-03 | 53 | 43 | 2 | PF02214 | |
| Domain | T1-type_BTB | 6.62e-03 | 53 | 43 | 2 | IPR003131 | |
| Domain | EGF_extracell | 8.42e-03 | 60 | 43 | 2 | IPR013111 | |
| Domain | EGF_2 | 8.42e-03 | 60 | 43 | 2 | PF07974 | |
| Pathway | WP_VITAMIN_A1_AND_A5X_PATHWAYS | 1.92e-07 | 6 | 31 | 3 | M48097 | |
| Pathway | PID_EPO_PATHWAY | 7.49e-07 | 33 | 31 | 4 | M233 | |
| Pathway | BIOCARTA_EPO_PATHWAY | 9.11e-06 | 19 | 31 | 3 | M12836 | |
| Pathway | BIOCARTA_EPO_PATHWAY | 1.07e-05 | 20 | 31 | 3 | MM1389 | |
| Pathway | WP_TH17_CELL_DIFFERENTIATION_PATHWAY | 1.50e-05 | 69 | 31 | 4 | M45541 | |
| Pathway | WP_NONSMALL_CELL_LUNG_CANCER | 1.77e-05 | 72 | 31 | 4 | M39738 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 1.89e-05 | 24 | 31 | 3 | M11520 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 2.14e-05 | 25 | 31 | 3 | MM1519 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 2.14e-05 | 25 | 31 | 3 | M27865 | |
| Pathway | PID_RXR_VDR_PATHWAY | 2.42e-05 | 26 | 31 | 3 | M162 | |
| Pathway | BIOCARTA_GH_PATHWAY | 2.72e-05 | 27 | 31 | 3 | M9043 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 2.72e-05 | 27 | 31 | 3 | MM14712 | |
| Pathway | WP_PDGFRBETA_PATHWAY | 3.38e-05 | 29 | 31 | 3 | M39616 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 3.38e-05 | 29 | 31 | 3 | M779 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 3.76e-05 | 30 | 31 | 3 | M207 | |
| Pathway | WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY | 3.76e-05 | 30 | 31 | 3 | MM15866 | |
| Pathway | WP_WHITE_FAT_CELL_DIFFERENTIATION | 4.57e-05 | 32 | 31 | 3 | M39333 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 4.66e-05 | 5 | 31 | 2 | M48987 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 4.66e-05 | 5 | 31 | 2 | M48986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 4.66e-05 | 5 | 31 | 2 | M49006 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 5.02e-05 | 33 | 31 | 3 | MM1448 | |
| Pathway | BIOCARTA_GH_PATHWAY | 5.02e-05 | 33 | 31 | 3 | MM1404 | |
| Pathway | WP_WHITE_FAT_CELL_DIFFERENTIATION | 5.02e-05 | 33 | 31 | 3 | MM15869 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 5.50e-05 | 34 | 31 | 3 | M16393 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 5.98e-05 | 98 | 31 | 4 | MM14545 | |
| Pathway | WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY | 6.01e-05 | 35 | 31 | 3 | M39488 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 6.98e-05 | 6 | 31 | 2 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 6.98e-05 | 6 | 31 | 2 | MM15621 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 7.27e-05 | 103 | 31 | 4 | M1073 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE | 7.71e-05 | 38 | 31 | 3 | M27536 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 7.71e-05 | 38 | 31 | 3 | M39657 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 7.71e-05 | 38 | 31 | 3 | MM15865 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 9.70e-05 | 41 | 31 | 3 | MM14546 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 9.76e-05 | 7 | 31 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 9.76e-05 | 7 | 31 | 2 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 9.76e-05 | 7 | 31 | 2 | M47646 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 9.76e-05 | 7 | 31 | 2 | M47430 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 9.76e-05 | 7 | 31 | 2 | M27907 | |
| Pathway | WP_VITAMIN_A_AND_CAROTENOID_METABOLISM | 1.12e-04 | 43 | 31 | 3 | M39554 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 1.12e-04 | 43 | 31 | 3 | M1056 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.12e-04 | 43 | 31 | 3 | M27443 | |
| Pathway | WP_RETINOL_METABOLISM | 1.20e-04 | 44 | 31 | 3 | MM15851 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CYTOKINE_JAK_STAT_SIGNALING_PATHWAY | 1.28e-04 | 45 | 31 | 3 | M47408 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 1.56e-04 | 48 | 31 | 3 | MM14987 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.66e-04 | 49 | 31 | 3 | MM15186 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.67e-04 | 9 | 31 | 2 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.67e-04 | 9 | 31 | 2 | MM1419 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.67e-04 | 9 | 31 | 2 | M8066 | |
| Pathway | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING | 2.08e-04 | 10 | 31 | 2 | M27330 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 2.08e-04 | 10 | 31 | 2 | M27898 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 2.08e-04 | 10 | 31 | 2 | M41731 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 2.08e-04 | 10 | 31 | 2 | MM15618 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 2.09e-04 | 53 | 31 | 3 | M8276 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 2.54e-04 | 11 | 31 | 2 | M27195 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 2.54e-04 | 11 | 31 | 2 | MM15578 | |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 2.60e-04 | 57 | 31 | 3 | M19888 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.60e-04 | 57 | 31 | 3 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.74e-04 | 58 | 31 | 3 | M2049 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING | 2.88e-04 | 59 | 31 | 3 | M39350 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 3.03e-04 | 60 | 31 | 3 | M40048 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 3.05e-04 | 12 | 31 | 2 | M27893 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR_IN_DISEASE | 3.50e-04 | 63 | 31 | 3 | M635 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 4.19e-04 | 14 | 31 | 2 | M27858 | |
| Pathway | PID_IL5_PATHWAY | 4.19e-04 | 14 | 31 | 2 | M135 | |
| Pathway | WP_ACUTE_MYELOID_LEUKEMIA | 4.38e-04 | 68 | 31 | 3 | M48322 | |
| Pathway | WP_FOXP3_IN_COVID19 | 4.83e-04 | 15 | 31 | 2 | M42573 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 4.83e-04 | 15 | 31 | 2 | M552 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 4.83e-04 | 15 | 31 | 2 | MM1412 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 4.83e-04 | 15 | 31 | 2 | M17681 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 4.83e-04 | 15 | 31 | 2 | MM14536 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING_PATHWAY | 4.97e-04 | 71 | 31 | 3 | MM15947 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 5.51e-04 | 16 | 31 | 2 | MM15710 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 5.51e-04 | 16 | 31 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 5.51e-04 | 16 | 31 | 2 | MM1420 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 5.51e-04 | 16 | 31 | 2 | M41733 | |
| Pathway | WP_IL9_SIGNALING | 6.24e-04 | 17 | 31 | 2 | M39644 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY | 6.24e-04 | 17 | 31 | 2 | M47905 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 6.55e-04 | 325 | 31 | 5 | M12868 | |
| Pathway | REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS | 7.01e-04 | 18 | 31 | 2 | M673 | |
| Pathway | WP_CANCER_PATHWAYS | 7.19e-04 | 507 | 31 | 6 | M48302 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 7.72e-04 | 191 | 31 | 4 | MM15586 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 7.82e-04 | 19 | 31 | 2 | M41732 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 8.68e-04 | 20 | 31 | 2 | MM15496 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 8.68e-04 | 20 | 31 | 2 | M39002 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 9.01e-04 | 87 | 31 | 3 | M12467 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 1.05e-03 | 22 | 31 | 2 | M7747 | |
| Pathway | WP_ERBB_SIGNALING | 1.06e-03 | 92 | 31 | 3 | M39715 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 1.15e-03 | 23 | 31 | 2 | MM1411 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 1.15e-03 | 23 | 31 | 2 | MM1424 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 1.15e-03 | 23 | 31 | 2 | M7897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL2_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY | 1.15e-03 | 23 | 31 | 2 | M47904 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 1.25e-03 | 24 | 31 | 2 | M519 | |
| Pathway | WP_IL3_SIGNALING_PATHWAY | 1.35e-03 | 100 | 31 | 3 | MM15879 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 1.35e-03 | 100 | 31 | 3 | MM15826 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 1.36e-03 | 25 | 31 | 2 | M41829 | |
| Pathway | WP_IL7_SIGNALING | 1.36e-03 | 25 | 31 | 2 | M39499 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 1.47e-03 | 26 | 31 | 2 | M27750 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 1.47e-03 | 26 | 31 | 2 | M39687 | |
| Pathway | PID_IL3_PATHWAY | 1.47e-03 | 26 | 31 | 2 | M182 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 1.47e-03 | 26 | 31 | 2 | MM15896 | |
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 9852056 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 7607068 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 7607067 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 11172439 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 8383767 | ||
| Pubmed | The molecular and genetic dissection of the retinoid signalling pathway. | 1.89e-09 | 3 | 44 | 3 | 8276261 | |
| Pubmed | Retinoic acid receptor gamma: specific immunodetection and phosphorylation. | 1.89e-09 | 3 | 44 | 3 | 1655807 | |
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 15831518 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 17252005 | ||
| Pubmed | Immunolocalization of retinoic acid receptors in rat, mouse and human ovary and uterus. | 1.89e-09 | 3 | 44 | 3 | 8136307 | |
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 8626453 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 24357724 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 8388780 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 9659935 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 7910825 | ||
| Pubmed | Tissue-specific expression of retinoic acid receptor isoform transcripts in the mouse embryo. | 1.89e-09 | 3 | 44 | 3 | 10842077 | |
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 8027572 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 2544807 | ||
| Pubmed | [Genetic expression and morphogenesis of the skin in vertebrates]. | 1.89e-09 | 3 | 44 | 3 | 8099268 | |
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 10100049 | ||
| Pubmed | Specificity of retinoid receptor gene expression in mouse cervical epithelia. | 1.89e-09 | 3 | 44 | 3 | 8156902 | |
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 9699718 | ||
| Pubmed | Retinoic acid receptor-beta: immunodetection and phosphorylation on tyrosine residues. | 1.89e-09 | 3 | 44 | 3 | 1283441 | |
| Pubmed | Characterization of retinoic acid receptor-deficient keratinocytes. | 1.89e-09 | 3 | 44 | 3 | 10748128 | |
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 36446525 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 2737701 | ||
| Pubmed | Immunohistochemical localization of the retinoic Acid receptors in human prostate. | 1.89e-09 | 3 | 44 | 3 | 12399530 | |
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 29848550 | ||
| Pubmed | Association of retinoic acid receptor genes with meningomyelocele. | 1.89e-09 | 3 | 44 | 3 | 21254357 | |
| Pubmed | Chromosomal assignment of retinoic acid receptor (RAR) genes in the human, mouse, and rat genomes. | 1.89e-09 | 3 | 44 | 3 | 1655630 | |
| Pubmed | 7.55e-09 | 4 | 44 | 3 | 19350571 | ||
| Pubmed | 7.55e-09 | 4 | 44 | 3 | 24050824 | ||
| Pubmed | 7.55e-09 | 4 | 44 | 3 | 12093741 | ||
| Pubmed | 7.55e-09 | 4 | 44 | 3 | 7626396 | ||
| Pubmed | 7.55e-09 | 4 | 44 | 3 | 17363914 | ||
| Pubmed | 7.55e-09 | 4 | 44 | 3 | 14691372 | ||
| Pubmed | 7.55e-09 | 4 | 44 | 3 | 18845237 | ||
| Pubmed | The retinoic acid receptors RARalpha and RARgamma are required for inner ear development. | 7.55e-09 | 4 | 44 | 3 | 12464434 | |
| Pubmed | 7.55e-09 | 4 | 44 | 3 | 9376317 | ||
| Pubmed | 7.55e-09 | 4 | 44 | 3 | 2556642 | ||
| Pubmed | Retinoic acid signalling in the development of branchial arches. | 7.55e-09 | 4 | 44 | 3 | 15380252 | |
| Pubmed | 7.55e-09 | 4 | 44 | 3 | 10869350 | ||
| Pubmed | Retinoic acid signaling regulates murine bronchial tubule formation. | 1.89e-08 | 5 | 44 | 3 | 12834868 | |
| Pubmed | 1.89e-08 | 5 | 44 | 3 | 19665987 | ||
| Pubmed | 1.89e-08 | 5 | 44 | 3 | 8152920 | ||
| Pubmed | 1.89e-08 | 5 | 44 | 3 | 1334737 | ||
| Pubmed | 1.89e-08 | 5 | 44 | 3 | 9053308 | ||
| Pubmed | High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. | 1.89e-08 | 5 | 44 | 3 | 8394014 | |
| Pubmed | 1.89e-08 | 5 | 44 | 3 | 9097025 | ||
| Pubmed | Retinal dysplasia and degeneration in RARbeta2/RARgamma2 compound mutant mice. | 1.89e-08 | 5 | 44 | 3 | 8681798 | |
| Pubmed | 1.89e-08 | 5 | 44 | 3 | 8174226 | ||
| Pubmed | Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells. | 1.89e-08 | 5 | 44 | 3 | 19006694 | |
| Pubmed | 1.89e-08 | 5 | 44 | 3 | 19345331 | ||
| Pubmed | The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development. | 3.77e-08 | 6 | 44 | 3 | 9806918 | |
| Pubmed | 3.77e-08 | 6 | 44 | 3 | 1966045 | ||
| Pubmed | Systematic immunolocalization of retinoid receptors in developing and adult mouse eyes. | 3.77e-08 | 6 | 44 | 3 | 11328745 | |
| Pubmed | A genetic dissection of the retinoid signalling pathway in the mouse. | 3.77e-08 | 6 | 44 | 3 | 10604193 | |
| Pubmed | 3.77e-08 | 6 | 44 | 3 | 1849812 | ||
| Pubmed | 3.77e-08 | 6 | 44 | 3 | 9153406 | ||
| Pubmed | 3.77e-08 | 6 | 44 | 3 | 9590554 | ||
| Pubmed | Roles of retinoic acid receptors in early embryonic morphogenesis and hindbrain patterning. | 3.77e-08 | 6 | 44 | 3 | 11493525 | |
| Pubmed | Spatial distributions of retinoic acid receptor gene transcripts in the prenatal mouse inner ear. | 3.77e-08 | 6 | 44 | 3 | 9548551 | |
| Pubmed | Functional specificity of the two retinoic acid receptor RAR and RXR families in myogenesis. | 3.77e-08 | 6 | 44 | 3 | 9464546 | |
| Pubmed | 3.77e-08 | 6 | 44 | 3 | 9075714 | ||
| Pubmed | Inflammatory chemokine release of astrocytes in vitro is reduced by all-trans retinoic acid. | 3.77e-08 | 6 | 44 | 3 | 20557428 | |
| Pubmed | 3.77e-08 | 6 | 44 | 3 | 8801169 | ||
| Pubmed | 3.77e-08 | 6 | 44 | 3 | 8801176 | ||
| Pubmed | 6.59e-08 | 7 | 44 | 3 | 17195188 | ||
| Pubmed | Dissecting the role of retinoic acid receptor isoforms in the CD8 response to infection. | 6.59e-08 | 7 | 44 | 3 | 24610012 | |
| Pubmed | Regulation of skeletal progenitor differentiation by the BMP and retinoid signaling pathways. | 6.59e-08 | 7 | 44 | 3 | 10684250 | |
| Pubmed | 6.59e-08 | 7 | 44 | 3 | 12665583 | ||
| Pubmed | Retinoic acid signaling is dispensable for somatic development and function in the mammalian ovary. | 6.59e-08 | 7 | 44 | 3 | 28274610 | |
| Pubmed | Differential contributions of AF-1 and AF-2 activities to the developmental functions of RXR alpha. | 6.59e-08 | 7 | 44 | 3 | 11493527 | |
| Pubmed | 6.59e-08 | 7 | 44 | 3 | 8397079 | ||
| Pubmed | Role of the retinoic acid receptor beta (RARbeta) during mouse development. | 6.59e-08 | 7 | 44 | 3 | 9240560 | |
| Pubmed | 6.59e-08 | 7 | 44 | 3 | 12360493 | ||
| Pubmed | 6.59e-08 | 7 | 44 | 3 | 15635645 | ||
| Pubmed | 6.59e-08 | 7 | 44 | 3 | 8090775 | ||
| Pubmed | Retinoic acid receptors exhibit cell-autonomous functions in cranial neural crest cells. | 1.05e-07 | 8 | 44 | 3 | 19777591 | |
| Pubmed | Expression of nuclear retinoic acid receptors during mouse odontogenesis. | 1.05e-07 | 8 | 44 | 3 | 7988794 | |
| Pubmed | Retinoids and adipose tissues: metabolism, cell differentiation and gene expression. | 1.05e-07 | 8 | 44 | 3 | 10094571 | |
| Pubmed | Prepubertal testis development relies on retinoic acid but not rexinoid receptors in Sertoli cells. | 1.05e-07 | 8 | 44 | 3 | 17124491 | |
| Pubmed | 1.13e-07 | 35 | 44 | 4 | 19389355 | ||
| Pubmed | 1.58e-07 | 9 | 44 | 3 | 8555112 | ||
| Pubmed | 1.58e-07 | 9 | 44 | 3 | 15644415 | ||
| Pubmed | 1.58e-07 | 9 | 44 | 3 | 16574820 | ||
| Pubmed | 1.58e-07 | 9 | 44 | 3 | 21722948 | ||
| Pubmed | 2.25e-07 | 10 | 44 | 3 | 17363140 | ||
| Pubmed | 2.25e-07 | 10 | 44 | 3 | 18539269 | ||
| Pubmed | 3.10e-07 | 11 | 44 | 3 | 29093497 | ||
| Pubmed | Reduced BMP4 abundance in Gata2 hypomorphic mutant mice result in uropathies resembling human CAKUT. | 3.10e-07 | 11 | 44 | 3 | 18233958 | |
| Pubmed | 4.12e-07 | 12 | 44 | 3 | 9022057 | ||
| Pubmed | Mapping of the mouse Rar loci encoding retinoic acid receptors RAR alpha, RAR beta and RAR gamma. | 4.12e-07 | 12 | 44 | 3 | 8251184 | |
| Pubmed | 4.12e-07 | 12 | 44 | 3 | 1377062 | ||
| Pubmed | 4.12e-07 | 12 | 44 | 3 | 26427057 | ||
| Pubmed | 4.12e-07 | 12 | 44 | 3 | 30166332 | ||
| Pubmed | Isolation and developmental expression of retinoic-acid-induced genes. | 4.12e-07 | 12 | 44 | 3 | 8314004 | |
| Pubmed | APBB3 RNF123 PLCG1 RARB USPL1 LRP1B ITGB8 ZMYM4 DYNC1H1 ZNF181 STAT5B | 4.19e-07 | 1285 | 44 | 11 | 35914814 | |
| Pubmed | 5.36e-07 | 13 | 44 | 3 | 29986869 | ||
| Pubmed | 6.81e-07 | 14 | 44 | 3 | 18561907 | ||
| Interaction | KCNG4 interactions | 6.72e-06 | 18 | 42 | 3 | int:KCNG4 | |
| Interaction | KCNG1 interactions | 1.09e-05 | 21 | 42 | 3 | int:KCNG1 | |
| Interaction | NCOR2 interactions | 1.69e-05 | 264 | 42 | 6 | int:NCOR2 | |
| Interaction | ITGB1BP2 interactions | 1.87e-05 | 25 | 42 | 3 | int:ITGB1BP2 | |
| Interaction | JAK2 interactions | 2.31e-05 | 165 | 42 | 5 | int:JAK2 | |
| Interaction | HACE1 interactions | 2.96e-05 | 29 | 42 | 3 | int:HACE1 | |
| Interaction | KCNS3 interactions | 6.22e-05 | 37 | 42 | 3 | int:KCNS3 | |
| Interaction | SMARCD3 interactions | 7.20e-05 | 107 | 42 | 4 | int:SMARCD3 | |
| Interaction | RARB interactions | 1.20e-04 | 46 | 42 | 3 | int:RARB | |
| Interaction | RXRG interactions | 1.28e-04 | 47 | 42 | 3 | int:RXRG | |
| Interaction | KCNV1 interactions | 1.51e-04 | 9 | 42 | 2 | int:KCNV1 | |
| Interaction | KCNG3 interactions | 1.51e-04 | 9 | 42 | 2 | int:KCNG3 | |
| Interaction | EPOR interactions | 1.54e-04 | 50 | 42 | 3 | int:EPOR | |
| Interaction | GHR interactions | 1.63e-04 | 51 | 42 | 3 | int:GHR | |
| GeneFamily | Potassium voltage-gated channels | 4.32e-05 | 40 | 31 | 3 | 274 | |
| GeneFamily | Nuclear hormone receptors | 7.97e-05 | 49 | 31 | 3 | 71 | |
| GeneFamily | SH2 domain containing | 6.79e-04 | 101 | 31 | 3 | 741 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-06 | 184 | 44 | 5 | a6dee97ee4ef9d89e11d17339e0dadaea1210ce5 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.38e-05 | 148 | 44 | 4 | 5729826e8d45bf995e2efa6707c49e264d12d112 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-05 | 161 | 44 | 4 | a006491c991e6a134be20ad75092a91f3b7c3c91 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.78e-05 | 177 | 44 | 4 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-M/X_cells_(MLN/GHRL+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-05 | 181 | 44 | 4 | cb17c904ab86d56dd30cac9b61acbb3b76f84ded | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_T-T_NK-NK_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.37e-05 | 186 | 44 | 4 | b099cb0902e9afb11218d70407d3cab212343c6d | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T-T_NK-NK_T_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.44e-05 | 187 | 44 | 4 | 3301e0fca8c436d136c71f1a8fd59b3bb11bdd83 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-05 | 189 | 44 | 4 | a959c9d6a0866582688a4204d625c1e5a123e93d | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-05 | 190 | 44 | 4 | 1803b1e7c36285f9eaabc3c6e9a9752c5908db3d | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 191 | 44 | 4 | 8597a8af294f24496c317d995f07eb5dcc25c13c | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 191 | 44 | 4 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-05 | 192 | 44 | 4 | 3617d2bc7e33d981f3ec349e9962d8d4bd822fbd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-05 | 193 | 44 | 4 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-05 | 193 | 44 | 4 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 194 | 44 | 4 | 80be44e9ddd9f6ddd9dff7cba0eb457431204c2d | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.06e-05 | 195 | 44 | 4 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.22e-05 | 197 | 44 | 4 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.15e-05 | 85 | 44 | 3 | 642755ed2b562dd5e599a04a2b9730e8d29aefe8 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.15e-05 | 85 | 44 | 3 | 2429bacccd103e5b2414264b4aff3103ed9d7cec | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_atypical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-04 | 148 | 44 | 3 | b7b5521162effc1024e7c399f690cd86d0b2f750 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.18e-04 | 148 | 44 | 3 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.18e-04 | 148 | 44 | 3 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.18e-04 | 148 | 44 | 3 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | 3'_v3-blood-Lymphocytic_Invariant-Inducer-like|blood / Manually curated celltypes from each tissue | 4.27e-04 | 149 | 44 | 3 | 75422e1a22736375e9ef439db0b2a5efa3f653a3 | |
| ToppCell | Ciliated_cells-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 4.44e-04 | 151 | 44 | 3 | 9d03ce73af15ef40c592d19b36aff46bebc14c40 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.44e-04 | 151 | 44 | 3 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.44e-04 | 151 | 44 | 3 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.52e-04 | 152 | 44 | 3 | 9391b46a441cf031665df1d142e3f65e98675eeb | |
| ToppCell | PND01-03-samps-Epithelial-Epithelial-non_alveolar|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.61e-04 | 153 | 44 | 3 | fc0d2d50aa3b6b2772bbf3626c9df5c5e8d7d11e | |
| ToppCell | PND01-03-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.61e-04 | 153 | 44 | 3 | 2482247d9c39c7b99bb45fb9153442f64fd6012f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-neuro-epithelial-Progenitor_(NEUROG3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.61e-04 | 153 | 44 | 3 | 20786807bba3bcd70ce744f8b6454e064199ed9f | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.70e-04 | 154 | 44 | 3 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.70e-04 | 154 | 44 | 3 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.79e-04 | 155 | 44 | 3 | babcb9e548f04ace8157d506d27c5941c692c491 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.79e-04 | 155 | 44 | 3 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.79e-04 | 155 | 44 | 3 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.79e-04 | 155 | 44 | 3 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.06e-04 | 158 | 44 | 3 | d78e7e52657dc094430291fec07e9c298be9e584 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-04 | 160 | 44 | 3 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-04 | 160 | 44 | 3 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-04 | 161 | 44 | 3 | 4f25eeabb841b0b9204cdd4e71d5e131e7868184 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.45e-04 | 162 | 44 | 3 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.45e-04 | 162 | 44 | 3 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.64e-04 | 164 | 44 | 3 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.74e-04 | 165 | 44 | 3 | 15fd9d21dccfa80656a6fa3b72286a6a9252d403 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-04 | 167 | 44 | 3 | 69caf4a53805f8c104d7dd8f88665fc992e23720 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-04 | 168 | 44 | 3 | de1042267407719f19eb3f580a5df0c9cd0e8273 | |
| ToppCell | Club_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 6.16e-04 | 169 | 44 | 3 | 03b303af8a26c6ff196507fe24f5bd3d75d7b1af | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.16e-04 | 169 | 44 | 3 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 6.37e-04 | 171 | 44 | 3 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-04 | 172 | 44 | 3 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 6.48e-04 | 172 | 44 | 3 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-04 | 172 | 44 | 3 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-04 | 173 | 44 | 3 | ca3d2a9562734f76127e3e7d54c10b63e95141bb | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-04 | 173 | 44 | 3 | 19a9e10885173d7712996be8660a3a5a7a9aa39f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.59e-04 | 173 | 44 | 3 | 95c723b09254ae7131fe5ba0841472502e83269b | |
| ToppCell | Control-CD4+_T_activated|Control / Disease group and Cell class | 6.70e-04 | 174 | 44 | 3 | 2b683e81b315ad22555314433aed5681feb48da8 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.70e-04 | 174 | 44 | 3 | c529f3674b784f872f4387ffdeb46aecb619976b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.81e-04 | 175 | 44 | 3 | 1d8da48236549c01381f777ce5b2937f9f86acc2 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-04 | 175 | 44 | 3 | 510c46bfd250ef83fcad8f6b01efbcca9d71a9a2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.81e-04 | 175 | 44 | 3 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.81e-04 | 175 | 44 | 3 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.93e-04 | 176 | 44 | 3 | 0710689e66deba179b0a8038cdd56b4834984f12 | |
| ToppCell | 3'_v3-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue | 6.93e-04 | 176 | 44 | 3 | b9da3deaf62622d47eb30b6be7548253eee95597 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.04e-04 | 177 | 44 | 3 | 921783ed0fe20294d2f384d9136924b679df01bb | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.04e-04 | 177 | 44 | 3 | 3cfde67b93f3986312f5e74e42504214d966e7dc | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.04e-04 | 177 | 44 | 3 | 12a52a12a87a31e501ced611f46a90d172ca7e35 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.04e-04 | 177 | 44 | 3 | f30d757ee8db7e10d547498dab6560473c6ed7c0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.16e-04 | 178 | 44 | 3 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.16e-04 | 178 | 44 | 3 | 6f61490d79cd1727ed2d5cc673823dd4efdafac1 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.16e-04 | 178 | 44 | 3 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-04 | 179 | 44 | 3 | b44e2d53b82c3c141bfc6539054b19708200a0d9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.27e-04 | 179 | 44 | 3 | 445eeb0356d9fd894aa33dd9f45d893b21424149 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.27e-04 | 179 | 44 | 3 | d16dc58b5b22762a5a3c875563ced18022d08908 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.27e-04 | 179 | 44 | 3 | 1ac79c82c52fa95bb4e170ab20fec0f648db2134 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.27e-04 | 179 | 44 | 3 | 065a50952e8703fa07767beb6b73a090bf378ca6 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.39e-04 | 180 | 44 | 3 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.39e-04 | 180 | 44 | 3 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.51e-04 | 181 | 44 | 3 | 2b53a65ca5616a7b9f64232c3e0b7212d1e2f063 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.51e-04 | 181 | 44 | 3 | 6aef84616e8d2faf54b7e9e6cd02f33c3066dabc | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.51e-04 | 181 | 44 | 3 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-04 | 181 | 44 | 3 | 35eefd874a892eaf21f24fdce89e7ea3b8ee285f | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-04 | 181 | 44 | 3 | e4c3e0eae9f21e78b5dd18cf017bd041ffc8c968 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-04 | 181 | 44 | 3 | c1b1e62440805800a3a600b1ddd79be1c9762598 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.51e-04 | 181 | 44 | 3 | 40df0afcb6848202da54670e84f22d7c3a515d01 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-04 | 181 | 44 | 3 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.51e-04 | 181 | 44 | 3 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.51e-04 | 181 | 44 | 3 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 7.51e-04 | 181 | 44 | 3 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.51e-04 | 181 | 44 | 3 | 40d3829ae4aaf81e8616c3499ff8933137fc1cc4 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-M/X_cells_(MLN/GHRL+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.51e-04 | 181 | 44 | 3 | af031661af28f99d906d8e013b4949133b44a2e6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.63e-04 | 182 | 44 | 3 | cc6f9d606a4f8717dc44928ceec2a257636043fd | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.63e-04 | 182 | 44 | 3 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 7.63e-04 | 182 | 44 | 3 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.63e-04 | 182 | 44 | 3 | 587636c0f127231de21acd8aa632b74ff22ca8c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.63e-04 | 182 | 44 | 3 | adfadd7893e74b3002f13f00875e3667d3493e0c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.63e-04 | 182 | 44 | 3 | 35b2a5625323bf0917214d3b82fafc4a8f5e75ff | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.63e-04 | 182 | 44 | 3 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 7.63e-04 | 182 | 44 | 3 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-6_RORB_HPCA|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.75e-04 | 183 | 44 | 3 | c7e94fe3e7669db9304b249979fef7a69c30a143 | |
| Drug | Tazarotene | 2.69e-08 | 4 | 44 | 3 | DB00799 | |
| Drug | Alitretinoin | 1.34e-07 | 6 | 44 | 3 | DB00523 | |
| Drug | Adapalene | 1.34e-07 | 6 | 44 | 3 | DB00210 | |
| Drug | Etretinate | 1.34e-07 | 6 | 44 | 3 | DB00926 | |
| Drug | Acitretin | 2.34e-07 | 7 | 44 | 3 | DB00459 | |
| Drug | HX 600 | 3.75e-07 | 8 | 44 | 3 | ctd:C104181 | |
| Drug | 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid | 3.75e-07 | 8 | 44 | 3 | ctd:C064545 | |
| Drug | Adapalene | 3.75e-07 | 8 | 44 | 3 | ctd:D000068816 | |
| Drug | TTNN | 3.75e-07 | 8 | 44 | 3 | CID000135754 | |
| Drug | 4-((4-(4-ethylphenyl)-2,2-dimethyl-(2H)-thiochromen-6-yl)ethynyl)benzoic acid | 3.75e-07 | 8 | 44 | 3 | ctd:C121616 | |
| Drug | UVI 3003 | 1.10e-06 | 11 | 44 | 3 | ctd:C525131 | |
| Drug | 4-hydroxyretinoic acid | 1.46e-06 | 12 | 44 | 3 | ctd:C019429 | |
| Drug | AC1L2E0P | 1.89e-06 | 307 | 44 | 7 | CID000019390 | |
| Drug | Cd2665 | 1.90e-06 | 13 | 44 | 3 | CID000216241 | |
| Drug | AC1L1DMQ | 2.41e-06 | 14 | 44 | 3 | CID000002418 | |
| Drug | Ro 8-8717 | 3.65e-06 | 2 | 44 | 2 | CID006438148 | |
| Drug | 4-carboxyphenylretinamide | 3.65e-06 | 2 | 44 | 2 | CID006439748 | |
| Drug | Tamibarotene | 3.65e-06 | 2 | 44 | 2 | DB04942 | |
| Drug | benzo(a)pyrene-1,6-quinone | 4.49e-06 | 17 | 44 | 3 | ctd:C030233 | |
| Drug | HX600 | 5.38e-06 | 18 | 44 | 3 | CID000128016 | |
| Drug | 3,4-didehydroretinoic acid | 5.38e-06 | 18 | 44 | 3 | CID000447276 | |
| Drug | benzo(a)pyrene-3,6-quinone | 5.38e-06 | 18 | 44 | 3 | ctd:C018003 | |
| Drug | 4-(1H-imidazol-1-yl)retinoic acid | 5.38e-06 | 18 | 44 | 3 | ctd:C496751 | |
| Drug | adapalene | 1.01e-05 | 22 | 44 | 3 | CID000060164 | |
| Drug | AGN 190299 | 1.09e-05 | 3 | 44 | 2 | ctd:C090766 | |
| Drug | 3-((4,6-diphenoxy-1,3,5-triazin-2-yl)amino)benzoic acid | 1.09e-05 | 3 | 44 | 2 | ctd:C529372 | |
| Drug | AC1L32JQ | 1.16e-05 | 23 | 44 | 3 | CID000133319 | |
| Drug | AC1L2X6Z | 1.91e-05 | 27 | 44 | 3 | CID000130325 | |
| Drug | AZD 1480 | 2.18e-05 | 4 | 44 | 2 | ctd:C545606 | |
| Drug | SRI 5898-21 | 2.18e-05 | 4 | 44 | 2 | CID006439757 | |
| Drug | tamibarotene | 2.30e-05 | 86 | 44 | 4 | CID000108143 | |
| Drug | AGN 193109 | 2.64e-05 | 30 | 44 | 3 | ctd:C096920 | |
| Drug | Ro 41-5253 | 2.64e-05 | 30 | 44 | 3 | ctd:C084904 | |
| Drug | AGN 193109 | 2.91e-05 | 31 | 44 | 3 | CID000177238 | |
| Drug | Hexetidine [141-94-6]; Up 200; 11.8uM; PC3; HT_HG-U133A | 3.28e-05 | 191 | 44 | 5 | 6319_UP | |
| Drug | CD367 | 3.53e-05 | 33 | 44 | 3 | CID000119342 | |
| Drug | Cd2366 | 3.64e-05 | 5 | 44 | 2 | CID006443796 | |
| Drug | sodium 4-phenylbutyrate; Down 200; 1000uM; MCF7; HG-U133A | 3.90e-05 | 198 | 44 | 5 | 407_DN | |
| Drug | Piroxicam [36322-90-4]; Up 200; 12uM; MCF7; HT_HG-U133A | 3.99e-05 | 199 | 44 | 5 | 7445_UP | |
| Drug | Vitamin A | 4.09e-05 | 200 | 44 | 5 | ctd:D014801 | |
| Drug | Ro 41-5253 | 5.00e-05 | 37 | 44 | 3 | CID005312120 | |
| Drug | 2-hydroxy-1-(2-((9-(4-methylcyclohexyl)-9H-pyrido(4',3'-4,5)pyrrolo(2,3-d)pyrimidin-2-yl)amino)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl)ethanone | 5.45e-05 | 6 | 44 | 2 | ctd:C000589290 | |
| Drug | tazarotene | 6.33e-05 | 40 | 44 | 3 | CID000005381 | |
| Drug | AC1L9K70 | 7.61e-05 | 228 | 44 | 5 | CID000446871 | |
| Drug | Etretinate-d3 | 9.03e-05 | 45 | 44 | 3 | CID000003312 | |
| Drug | 2-naphthoic acid | 1.01e-04 | 8 | 44 | 2 | CID000007123 | |
| Drug | retinyl methyl ether | 1.30e-04 | 9 | 44 | 2 | CID006436634 | |
| Drug | 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid | 1.31e-04 | 51 | 44 | 3 | ctd:C038864 | |
| Drug | E 4031 | 1.56e-04 | 54 | 44 | 3 | CID000003184 | |
| Drug | HX 630 | 1.63e-04 | 10 | 44 | 2 | ctd:C422175 | |
| Drug | 3,5-di-tert-butylchalcone 4'-carboxylic acid | 1.63e-04 | 10 | 44 | 2 | ctd:C054189 | |
| Drug | N'-(11H-indolo(3,2-c)quinolin-6-yl)-N,N-dimethylethane-1,2-diamine | 1.63e-04 | 10 | 44 | 2 | ctd:C524250 | |
| Drug | 2,4-dihydroxy-N-(4-hydroxyphenyl)benzamide | 1.63e-04 | 10 | 44 | 2 | ctd:C585912 | |
| Drug | CEPC | 1.63e-04 | 10 | 44 | 2 | CID000011483 | |
| Drug | CK 6 | 1.93e-04 | 58 | 44 | 3 | CID000447960 | |
| Drug | tazarotene | 1.99e-04 | 11 | 44 | 2 | ctd:C086827 | |
| Drug | Organothiophosphates | 1.99e-04 | 11 | 44 | 2 | ctd:D063086 | |
| Drug | 2-C5 | 2.58e-04 | 64 | 44 | 3 | CID005287467 | |
| Drug | tazarotenic acid | 2.81e-04 | 13 | 44 | 2 | CID000147525 | |
| Drug | Ro 13-6298 | 2.81e-04 | 13 | 44 | 2 | CID006437076 | |
| Drug | quizartinib | 2.81e-04 | 13 | 44 | 2 | ctd:C544967 | |
| Drug | ponatinib | 3.09e-04 | 68 | 44 | 3 | ctd:C545373 | |
| Drug | retinamide | 3.23e-04 | 69 | 44 | 3 | CID005370221 | |
| Drug | 9-cis-acitretin | 3.51e-04 | 71 | 44 | 3 | CID000041317 | |
| Drug | AC1L1JIR | 3.66e-04 | 72 | 44 | 3 | CID000005058 | |
| Drug | TAC 101 | 4.31e-04 | 16 | 44 | 2 | ctd:C112689 | |
| Drug | Griseofulvin | 4.46e-04 | 77 | 44 | 3 | ctd:D006118 | |
| Drug | AC1L1KPQ | 4.63e-04 | 78 | 44 | 3 | CID000005602 | |
| Drug | protoporphyrin IX dimethyl ester | 4.87e-04 | 17 | 44 | 2 | CID000194637 | |
| Drug | enilconazole | 4.87e-04 | 17 | 44 | 2 | ctd:C017435 | |
| Drug | A-74702 | 4.99e-04 | 80 | 44 | 3 | CID000452307 | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 5.01e-04 | 191 | 44 | 4 | 6236_UP | |
| Drug | Dicumarol [66-76-2]; Up 200; 11.8uM; HL60; HT_HG-U133A | 5.11e-04 | 192 | 44 | 4 | 2561_UP | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 5.21e-04 | 193 | 44 | 4 | 2209_DN | |
| Drug | Tadjakonine [11087-94-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 5.42e-04 | 195 | 44 | 4 | 4424_UP | |
| Drug | Kaempferol [520-18-3]; Up 200; 14uM; HL60; HT_HG-U133A | 5.42e-04 | 195 | 44 | 4 | 6157_UP | |
| Drug | SR11237 | 5.48e-04 | 18 | 44 | 2 | CID000127019 | |
| Drug | Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 7353_DN | |
| Drug | Benzbromarone [3562-84-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 5015_DN | |
| Drug | Ipratropium bromide [22254-24-6]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 2762_UP | |
| Drug | Ketoprofen [22071-15-4]; Up 200; 15.8uM; PC3; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 3729_UP | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; PC3; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 4548_DN | |
| Drug | Adamantamine fumarate [80789-67-9]; Up 200; 9.6uM; PC3; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 4222_UP | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 6813_UP | |
| Drug | Brinzolamide [138890-62-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 5016_UP | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 5.63e-04 | 197 | 44 | 4 | 1055_UP | |
| Drug | Seneciphylline [480-81-9]; Up 200; 12uM; PC3; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 4238_UP | |
| Drug | Dimethadione [695-53-4]; Down 200; 31uM; MCF7; HT_HG-U133A | 5.74e-04 | 198 | 44 | 4 | 3367_DN | |
| Drug | Milrinone [78415-72-2]; Down 200; 19uM; MCF7; HT_HG-U133A | 5.74e-04 | 198 | 44 | 4 | 7210_DN | |
| Drug | Suxibuzone [27470-51-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 5.74e-04 | 198 | 44 | 4 | 7163_DN | |
| Drug | Loracarbef [121961-22-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 5.74e-04 | 198 | 44 | 4 | 5492_UP | |
| Drug | aspirin, USP; Up 200; 100uM; HL60; HT_HG-U133A | 5.74e-04 | 198 | 44 | 4 | 1145_UP | |
| Drug | PHA-00767505E [723337-45-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.74e-04 | 198 | 44 | 4 | 6550_UP | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 5.74e-04 | 198 | 44 | 4 | 4704_DN | |
| Drug | SC-58125; Up 200; 10uM; SKMEL5; HG-U133A | 5.85e-04 | 199 | 44 | 4 | 507_UP | |
| Drug | Esculin Hydrate [531-75-9]; Up 200; 11.8uM; HL60; HT_HG-U133A | 5.85e-04 | 199 | 44 | 4 | 3052_UP | |
| Drug | Cefazolin sodium salt [27164-46-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 5.85e-04 | 199 | 44 | 4 | 4708_DN | |
| Drug | Dioxybenzone [131-53-3]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 5.85e-04 | 199 | 44 | 4 | 6478_UP | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; HL60; HT_HG-U133A | 5.85e-04 | 199 | 44 | 4 | 2543_UP | |
| Drug | Clidinium bromide [3485-62-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 5.96e-04 | 200 | 44 | 4 | 6837_UP | |
| Disease | Neuralgia-Neuritis, Sciatic Nerve | 1.07e-05 | 4 | 40 | 2 | C0751924 | |
| Disease | Sciatic Nerve Palsy | 1.07e-05 | 4 | 40 | 2 | C0751925 | |
| Disease | Lesion of Sciatic Nerve | 1.07e-05 | 4 | 40 | 2 | C0154748 | |
| Disease | Sciatic Neuritis | 1.07e-05 | 4 | 40 | 2 | C0242013 | |
| Disease | Sciatic Neuropathy | 1.07e-05 | 4 | 40 | 2 | C0149940 | |
| Disease | Granulomatous Slack Skin | 4.07e-04 | 22 | 40 | 2 | C0376407 | |
| Disease | Lymphoma, T-Cell, Cutaneous | 4.45e-04 | 23 | 40 | 2 | C0079773 | |
| Disease | Malignant neoplasm of breast | 5.41e-04 | 1074 | 40 | 7 | C0006142 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 5.70e-04 | 26 | 40 | 2 | DOID:234 (is_implicated_in) | |
| Disease | gastric adenocarcinoma (is_marker_for) | 6.62e-04 | 28 | 40 | 2 | DOID:3717 (is_marker_for) | |
| Disease | frontotemporal dementia | 8.66e-04 | 32 | 40 | 2 | MONDO_0017276 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 8.90e-04 | 139 | 40 | 3 | DOID:3908 (is_implicated_in) | |
| Disease | Inflammatory Bowel Diseases | 1.04e-03 | 35 | 40 | 2 | C0021390 | |
| Disease | epilepsy (implicated_via_orthology) | 1.41e-03 | 163 | 40 | 3 | DOID:1826 (implicated_via_orthology) | |
| Disease | Combined immunodeficiency | 1.42e-03 | 41 | 40 | 2 | C0494261 | |
| Disease | body surface area | 1.69e-03 | 643 | 40 | 5 | EFO_0022196 | |
| Disease | Acute Promyelocytic Leukemia | 1.79e-03 | 46 | 40 | 2 | C0023487 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 2.02e-03 | 49 | 40 | 2 | DOID:3910 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | 2.48e-03 | 702 | 40 | 5 | C0009402 | |
| Disease | non-lobar intracerebral hemorrhage | 3.32e-03 | 63 | 40 | 2 | EFO_0010178 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HALSGKNMCNYQLVC | 191 | Q96N23 | |
| CQIAGVCQQMCVNYV | 316 | Q9HCU0 | |
| IHTYQVCKVMEQNQN | 96 | P54756 | |
| HNYMCNCVIQDFQAS | 251 | O96019 | |
| MKALQCHQEACANIL | 111 | Q9BXX3 | |
| CVYKCVCQQHSEQMY | 166 | Q86Y37 | |
| IQKNMVYTCHRDKNC | 116 | P10276 | |
| IQKNMIYTCHRDKNC | 116 | P10826 | |
| NMVYTCHRDKNCIIN | 121 | P13631 | |
| GLVHLCCNKVQNYSM | 176 | Q5VTA0 | |
| QQLNCQYKCTMVRNS | 121 | Q9NZR2 | |
| NACQKYQAQSMFLCD | 406 | Q8IYA8 | |
| IANAQMENCAIIYCN | 31 | Q9H252 | |
| AAAELQQYCMQNACK | 31 | P50151 | |
| QQYCMQNACKDALLV | 36 | P50151 | |
| RYCMCNPEVVQQFHN | 761 | Q9UPP2 | |
| QCKTSCALMEQQHYV | 656 | P26012 | |
| KHCQQKYNVSCIMIL | 636 | Q92794 | |
| EAVQAACMVQYQKCL | 401 | O95704 | |
| SCCQARYHQKKEQMN | 131 | Q14721 | |
| CCQARYHQKKEQMNE | 136 | Q92953 | |
| MQYLHCCLQIAPNQE | 1 | Q8N9R0 | |
| QDHNKAGQEMCYVCL | 316 | Q6ZN84 | |
| MNISIYCQAAIKNCQ | 46 | Q5VWK5 | |
| NQNFCVPCYEKQHAM | 146 | Q14192 | |
| VPCYEKQHAMQCVQC | 151 | Q14192 | |
| HQQALQEYILMCCQC | 331 | P49356 | |
| MLHQACRNVAQYNAN | 2461 | Q14204 | |
| ICQHLCYLSMVVQEN | 1141 | Q92833 | |
| NEQLQEHCAMAIYQC | 686 | Q5T2S8 | |
| ILNNCCVMEYHQATG | 396 | P51692 | |
| DSLVEQCIQYCHKNM | 241 | Q6NSI8 | |
| QCIQYCHKNMNAIVA | 246 | Q6NSI8 | |
| NQTAHMLACYRKNCA | 811 | O94855 | |
| ILNNCCVMEYHQATG | 396 | P42229 | |
| CSQCGHQYQNRHMKS | 361 | Q5W0Q7 | |
| KECGNLYCHNMQLTL | 101 | Q5EBM4 | |
| ACINQHLMNNKDCFF | 1276 | Q5XPI4 | |
| HCSIAQQRNMAQYFK | 416 | P19174 | |
| YHILNMCNIDVTQQC | 306 | Q9HBG4 | |
| MYLKESHNYQCRCQQ | 186 | Q9UJU3 | |
| SHNYQCRCQQISMKN | 191 | Q9UJU3 | |
| HMIQKNQCLFTNTQC | 61 | Q9UL40 | |
| QKKHALRCYCQAMQV | 576 | Q9Y2L5 | |
| CHSLNVNCVDYMGQN | 121 | Q9Y210 | |
| MCQKNAVIRHEVNYQ | 446 | Q5VZL5 | |
| QRIHTMEKQYECNKC | 396 | Q2M3W8 | |
| ANMGQECIKCHINVY | 186 | Q8N2G6 |